EE281 Cost-Effectiveness Analysis of Bimekizumab in Patients With Axial Spondyloarthritis (AXSPA) in Greece
Abstract
Authors
M Koulentaki S Ravanidis D Daoussis T Dimitroulas C Papagoras P Sfikakis V Kountouris M Feretos G Kourlaba N Lyris D Willems